Mass Innovation Labs is working to change the way biopharmaceutical companies conduct research by providing a “crossroads” for CRO service providers, vendors, and investors.
Rutgers leading continuous manufacturing guidance efforts
Industry will be encouraged to adopt continuous manufacturing methods following the regulatory success of Janssen’s Prezista, says Rutgers University associate director and Interphex speaker Doug Hausner.
INC takes on a biopharma expert, Catalent aims to accelerate European growth, and more from AbelsonTaylor and CluePoints in this week's People on the Move column.
HUYA Bioscience says it will strengthen bonds between Chinese drug innovators and worldwide developers and through its new partnership with the Tianjin Institute of Pharmaceutical Research (TIPR).
Establishment of complex regulated preclinical studies in China is going to take a lot longer than expected, says CRL, with significant progress taking at least five years.
GlaxoSmithKline (GSK) has today opened a new medicinal chemistry
laboratory in Singapore and plans to double the number of
researchers hired at the site to 60.
Tripos has announced the sale of its Discovery Informatics
Business, as an initial step towards liquidation, in light of the
current trend to low-cost Asian outsourcing.
UK-based Synexus Clinical Research has formed the first
patient-recruitment site management organisation (SMO) in India to
cash in on India's burgeoning clinical research market.
Tekcel, a sample management company for life science research, has
acquired assets of Biophile that includes its ultra low temperature
(minus 80 degrees C) sample management systems designed for
research applications in the drug discovery...
